SymptomsBy Mayo Clinic staff
The signs and symptoms of postherpetic neuralgia are generally limited to the area of your skin where the shingles outbreak first occurred — most commonly in a band around your trunk, usually on just one side of your body.
Signs and symptoms may include:
- Pain. The pain associated with postherpetic neuralgia most commonly has been described as burning, sharp and jabbing, or deep and aching.
- Sensitivity to light touch. People who have postherpetic neuralgia often cannot bear even the touch of clothing on the affected skin, a condition called allodynia.
- Itching and numbness. Less commonly, postherpetic neuralgia can produce an itchy feeling or numbness.
- Weakness or paralysis. In rare cases, you might also experience muscle weakness or paralysis if the nerves involved also control muscle movement.
When to see a doctor
See a doctor at the first sign of shingles. Often the pain starts before you notice a rash. Your risk of developing postherpetic neuralgia is cut in half if you begin taking antiviral medications within 72 hours of developing the shingles rash. While steroids are sometimes prescribed for a more rapid resolution of the shingles rash and to provide short-term pain relief, their role in preventing postherpetic neuralgia has not been proved.
Treatment of postherpetic neuralgia. American Academy of Neurology. http://www.aan.com/professionals/practice/pdfs/pn_guideline_patients.pdf. Accessed July 3, 2012.
- Bajwa ZH, et al. Postherpetic neuralgia. http://www.uptodate.com/home/index.html. Accessed July 3, 2012.
- Watson P. Postherpetic neuralgia. American Family Physician. 2011;84:690.
- Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, U.K.; New York, N.Y.: Mosby Elsevier; 2010. http://www.mdconsult.com/books/about.do?about=true&eid=4-u1.0-B978-0-7234-3541-9..X0001-6--TOP&isbn=978-0-7234-3541-9&uniqId=230100505-57. Accessed July 3, 2012.
- Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label change. U.S. Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213264.htm. Accessed July 3, 2012.
- Watson JC (expert opinion). Mayo Clinic, Rochester, Minn. July 17, 2012.
- Irving GA, et al. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clinical Journal of Pain. 2012;28:101.
- Centers for Disease Control and Prevention, et al. Update on herpes zoster vaccine: Licensure for persons aged 50 through 59 years. MMWR. 2011;60:44. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a5.htm?s_cid=mm6044a5_w. Accessed July 18, 2012.